Glucose metabolism in triple-negative breast cancer cells

No Pathway Network information available for Glucose metabolism in triple-negative breast cancer cells

Pathways in the Glucose metabolism in triple-negative breast cancer cells SuperPath

#	Name	Source	Genes
1	Glucose metabolism in triple-negative breast cancer cells	WikiPathways	HK1 LDHA PDK1 PDP1 PFKP PKM SLC16A1 SLC2A1 (see all 8) (see less)

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	SLC16A1	Solute Carrier Family 16 Member 1	Protein Coding	1
2	SLC2A1	Solute Carrier Family 2 Member 1	Protein Coding	1
3	PDP1	Pyruvate Dehydrogenase Phosphatase Catalytic Subunit 1	Protein Coding	1
4	PKM	Pyruvate Kinase M1/2	Protein Coding	1
5	PFKP	Phosphofructokinase, Platelet	Protein Coding	1
6	LDHA	Lactate Dehydrogenase A	Protein Coding	1
7	HK1	Hexokinase 1	Protein Coding	1
8	PDK1	Pyruvate Dehydrogenase Kinase 1	Protein Coding	1

Disorders associated with Glucose metabolism in triple-negative breast cancer cells SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Anemia, congenital, nonspherocytic hemolytic, 5	Enrichment	HK1	3.23
2	Stomatin-deficient cryohydrocytosis with neurologic defects	Enrichment	SLC2A1	3.23
3	Erythrocyte lactate transporter defect	Enrichment	SLC16A1	3.23
4	Retinitis pigmentosa 79	Enrichment	HK1	3.23
5	Pyruvate dehydrogenase phosphatase deficiency	Enrichment	PDP1	3.23
6	Neuropathy, hereditary motor and sensory, russe type	Enrichment	HK1	3.23
7	Neurodevelopmental disorder with visual defects and brain anomalies	Enrichment	HK1	3.23
8	Epilepsy, idiopathic generalized 12	Enrichment	SLC2A1	3.23
9	Epilepsy with myoclonic absences	Enrichment	SLC2A1	3.23
10	Hereditary cryohydrocytosis with reduced stomatin	Enrichment	SLC2A1	3.23
11	Fanconi-bickel syndrome	Enrichment	LDHA	2.93
12	Dystonia 9	Enrichment	SLC2A1	2.93
13	Glut1 deficiency syndrome 1	Enrichment	SLC2A1	2.93
14	Monocarboxylate transporter 1 deficiency	Enrichment	SLC16A1	2.93
15	Glucose transporter type 1 deficiency syndrome	Enrichment	SLC2A1	2.93
16	Hyperinsulinemic hypoglycemia, familial, 7	Enrichment	SLC16A1	2.93
17	Ketoacidosis due to monocarboxylate transporter-1 deficiency	Enrichment	SLC16A1	2.93
18	Glut1 deficiency syndrome 2	Enrichment	SLC2A1	2.75
19	Chromosome 17q23.1-q23.2 deletion syndrome	Enrichment	SLC2A1	2.75
20	Paroxysmal dystonia	Enrichment	SLC2A1	2.38
21	Alternating hemiplegia of childhood	Enrichment	SLC2A1	2.33
22	Myoclonic-atonic epilepsy	Enrichment	SLC2A1	2.28
23	Developmental and epileptic encephalopathy 1	Enrichment	SLC2A1	1.83
24	Strabismus	Enrichment	SLC2A1	1.80
25	Epilepsy	Enrichment	SLC2A1	1.63
26	Benign epilepsy with centrotemporal spikes	Enrichment	SLC2A1	1.62
27	Centralopathic epilepsy	Enrichment	SLC2A1	1.60
28	West syndrome	Enrichment	SLC2A1	1.59
29	Autism spectrum disorder	Enrichment	HK1	1.20
30	Microcephaly	Enrichment	SLC2A1	1.15
31	Retinitis pigmentosa	Enrichment	HK1	0.93
32	Hereditary retinal dystrophy	Enrichment	HK1	0.80
33	Fundus dystrophy	Enrichment	HK1	0.80

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

Glucose metabolism in triple-negative breast cancer cells

Pathway Network for Glucose metabolism in triple-negative breast cancer cells

Member Pathways for Glucose metabolism in triple-negative breast cancer cells

Pathways in the Glucose metabolism in triple-negative breast cancer cells SuperPath

Associated Genes for Glucose metabolism in triple-negative breast cancer cells

Associated Disorders for Glucose metabolism in triple-negative breast cancer cells

Disorders associated with Glucose metabolism in triple-negative breast cancer cells SuperPath

STRING Interaction Network for Glucose metabolism in triple-negative breast cancer cells

Sources for Glucose metabolism in triple-negative breast cancer cells